Google and Novartis in smart lens pact
This article was originally published in Clinica
Novartis's Alcon unit has signed a deal with Google to license the latter's "smart lens" technology, which could lead to medical innovations such as constant blood sugar monitoring via the eye, or adaptive focusing of contact lenses.
You may also be interested in...
Galvani Bioelectronics, the new joint venture between Google’s health-care spinoff Verily and drug giant GSK, will develop a new generation of "bioelectronic medicines" – neuromodulating therapies to treat a wide range of chronic diseases. Brian Otis, CTO of Verily, tells Medtech Insight how the devices that will come out of Galvani differ from existing neuromodulation technologies.
Infographic: A snapshot of executive compensation at the world’s biggest pharmaceutical companies. Explore our interactive dashboard and visualizations comparing remuneration packages with other key company metrics.
Addressing health care inequities, providing a nurturing environment for employees and learning from the pandemic were among the aims expressed by executives surveyed by Scrip.